NCT02230085View on ClinicalTrials.gov

Adherence Risk Indicator Validation Study

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

December 31, 2015

Conditions
Obstructive Sleep Apnea
Interventions
OTHER

Administration of the questionnaire and monitoring of CPAP adherence

Trial Locations (1)

83704

EverythingCPAP, Boise

All Listed Sponsors
lead

Fisher and Paykel Healthcare

INDUSTRY

NCT02230085 - Adherence Risk Indicator Validation Study | Biotech Hunter | Biotech Hunter